 |
InterPro: IPR004109 Peptidase S29, hepatitus C polyprotein NS3
Protein matches
|
UniProtKB Matches: 5130 proteins |
|
Accession
|
IPR004109 Peptidase_S29 |
Type
|
Domain |
Signatures
|
|
InterPro Relationships
|
|
Parent
|
IPR009003 Serine/cysteine peptidase, trypsin-like
|
GO Term annotation
|
|
Process
|
GO:0006508 proteolysis
GO:0019087 transformation of host cell by virus
|
|
Function
|
GO:0008236 serine-type peptidase activity
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold:
- Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins.
- Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule.
In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding.
Proteolytic enzymes that exploit serine in their catalytic activity are ubiquitous, being found in viruses, bacteria and eukaryotes [1]. They include a wide range of peptidase activity, including exopeptidase, endopeptidase, oligopeptidase and omega-peptidase activity. Over 20 families (denoted S1 - S66) of serine protease have been identified, these being grouped into clans on the basis of structural similarity and other functional evidence [1]. Structures are known for members of the clans and the structures indicate that some appear to be totally unrelated, suggesting different evolutionary origins for the serine peptidases [1].
Not withstanding their different evolutionary origins, there are similarities in the reaction mechanisms of several peptidases. Chymotrypsin, subtilisin and carboxypeptidase C have a catalytic triad of serine, aspartate and histidine in common: serine acts as a nucleophile, aspartate as an electrophile, and histidine as a base [1]. The geometric orientations of the catalytic residues are similar between families, despite different protein folds [1]. The linear arrangements of the catalytic residues commonly reflect clan relationships. For example the catalytic triad in the chymotrypsin clan (PA) is ordered HDS, but is ordered DHS in the subtilisin clan (SB) and SDH in the carboxypeptidase clan (SC) [1, 2].
This signature identifies the Hepatitis C virus NS3 protein as a serine protease which belongs to MEROPS peptidase family S29 (hepacivirin family, clan PA(S)), which has a trypsin-like fold. The non-structural (NS) protein NS3 is one of the NS proteins involved in replication of the HCV genome. The NS2 proteinase (IPR002518), a zinc-dependent enzyme, performs a single proteolytic cut to release the N terminus of NS3. The action of NS3 proteinase (NS3P), which resides in the N-terminal one-third of the NS3 protein, then yields all remaining non-structural proteins. The C-terminal two-thirds of the NS3 protein contain a helicase. The functional relationship between the proteinase and helicase domains is unknown. NS3 has a structural zinc-binding site and requires cofactor NS4. It has been suggested that the NS3 serine protease of hepatitus C is involved in cell transformation and that the ability to transform requires an active enzyme [3].
|
Structural links
|
|
Database links
|
Pfam Clan: CL0124.11
|
Example proteins
|
O92972 Genome polyprotein
More proteins
Example Proteins Key
| InterPro entry accession number/name and structure databases |
Colour code |
| IPR002521 |
Hepatitis C virus core protein |
 |
| IPR007094 |
RNA-directed RNA polymerase, positive-strand RNA eukaryotic virus |
 |
| IPR002522 |
Hepatitis C virus capsid protein |
 |
| IPR002531 |
Hepatitis C virus non-structural protein E2/NS1 |
 |
| IPR002166 |
RNA dependent RNA polymerase, hepatitis C virus |
 |
| IPR014021 |
Helicase, superfamily 1/2, ATP-binding domain |
 |
| IPR004109 |
Peptidase S29, hepatitus C polyprotein NS3 |
 |
| IPR009003 |
Serine/cysteine peptidase, trypsin-like |
 |
| IPR013192 |
Zinc finger, hepatitis C virus non-structural 5a-type |
 |
| IPR013193 |
Hepatitis C virus non-structural 5a, region 1b |
 |
| IPR002519 |
Hepatitis C virus envelope glycoprotein E1 |
 |
| IPR001650 |
DNA/RNA helicase, C-terminal |
 |
| IPR002518 |
Peptidase C18, hepatitis C virus endopeptidase 2 |
 |
| IPR001490 |
Hepatitis C virus non-structural protein NS4b |
 |
| IPR000745 |
Hepatitis C virus non-structural protein NS4a |
 |
| IPR002868 |
Hepatitis C virus non-structural 5a protein |
 |
| IPR014001 |
DEAD-like helicase, N-terminal |
 |
|
PDB Chain |
 |
|
CATH Domain |
 |
|
SWISS-MODEL |
 |
|
SCOP Domain |
 |
|
Publications
|
|
1.
|
Rawlings ND, Barrett AJ.
Families of serine peptidases.
Meth. Enzymol. 244 19-61 1994
[PubMed: 7845208]
http://dx.doi.org/10.1016/0076-6879(94)44004-2
|
|
2.
|
Rawlings ND, Barrett AJ.
Evolutionary families of peptidases.
Biochem. J. 290 ( Pt 1) 205-18 1993
[PubMed: 8439290]
http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=EBI&pubmedid=8439290&action=stream&blobtype=pdf
|
|
3.
|
Zemel R, Gerechet S, Greif H, Bachmatove L, Birk Y, Golan-Goldhirsh A, Kunin M, Berdichevsky Y, Benhar I, Tur-Kaspa R.
Cell transformation induced by hepatitis C virus NS3 serine protease.
J. Viral Hepat. 8 96-102 2001
[PubMed: 11264729]
http://dx.doi.org/10.1046/j.1365-2893.2001.00283.x
|
Additional Reading
|
|
Arasappan A, Njoroge FG, Chen KX, Venkatraman S, Parekh TN, Gu H, Pichardo J, Butkiewicz N, Prongay A, Madison V, Girijavallabhan V.
P2-P4 macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease.
Bioorg. Med. Chem. Lett. 16 2006 3960-5
[PubMed: 16730985]
http://dx.doi.org/10.1016/j.bmcl.2006.05.022
|
|
Bogen SL, Ruan S, Liu R, Agrawal S, Pichardo J, Prongay A, Baroudy B, Saksena AK, Girijavallabhan V, Njoroge FG.
Depeptidization efforts on P3-P2' alpha-ketoamide inhibitors of HCV NS3-4A serine protease: effect on HCV replicon activity.
Bioorg. Med. Chem. Lett. 16 2006 1621-7
[PubMed: 16387495]
http://dx.doi.org/10.1016/j.bmcl.2005.12.013
|
|
Urbani A, Bianchi E, Narjes F, Tramontano A, De Francesco R, Steinkuhler C, Pessi A.
Substrate specificity of the hepatitis C virus serine protease NS3.
J. Biol. Chem. 272 1997 9204-9
[PubMed: 9083052]
http://dx.doi.org/10.1074/jbc.272.14.9204
|
|
Love RA, Parge HE, Wickersham JA, Hostomsky Z, Habuka N, Moomaw EW, Adachi T, Hostomska Z.
The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site.
Cell 87 1996 331-42
[PubMed: 8861916]
http://dx.doi.org/10.1016/S0092-8674(00)81350-1
|
|
Venkatraman S, Njoroge FG, Wu W, Girijavallabhan V, Prongay AJ, Butkiewicz N, Pichardo J.
Novel inhibitors of hepatitis C NS3-NS4A serine protease derived from 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid.
Bioorg. Med. Chem. Lett. 16 2006 1628-32
[PubMed: 16413182]
http://dx.doi.org/10.1016/j.bmcl.2005.12.046
|
|
Yan Y, Li Y, Munshi S, Sardana V, Cole JL, Sardana M, Steinkuehler C, Tomei L, De Francesco R, Kuo LC, Chen Z.
Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.
Protein Sci. 7 1998 837-47
[PubMed: 9568891]
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=EBI&pubmedid=9568891
|
|
Perni RB, Chandorkar G, Cottrell KM, Gates CA, Lin C, Lin K, Luong YP, Maxwell JP, Murcko MA, Pitlik J, Rao G, Schairer WC, Van Drie J, Wei Y.
Inhibitors of hepatitis C virus NS3.4A protease. Effect of P4 capping groups on inhibitory potency and pharmacokinetics.
Bioorg. Med. Chem. Lett. 17 2007 3406-11
[PubMed: 17482818]
http://dx.doi.org/10.1016/j.bmcl.2007.03.090
|
|
Prongay AJ, Guo Z, Yao N, Pichardo J, Fischmann T, Strickland C, Myers J Jr, Weber PC, Beyer BM, Ingram R, Hong Z, Prosise WW, Ramanathan L, Taremi SS, Yarosh-Tomaine T, Zhang R, Senior M, Yang RS, Malcolm B, Arasappan A, Bennett F, Bogen SL, Chen K, Jao E, Liu YT, Lovey RG, Saksena AK, Venkatraman S, Girijavallabhan V, Njoroge FG, Madison V.
Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization.
J. Med. Chem. 50 2007 2310-8
[PubMed: 17444623]
http://dx.doi.org/10.1021/jm060173k
|
|